Acknowledgements This work was funded by grants RTI2018-094052-B-100 funded by MICIU/AEI/10.13039/501100011033/ and by ERDF A way of making Europe and PID-2021-122766OB-100 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU, P2022/BMD-7227 (Comunidad de Madrid, Spain) and CIBERDdem (ISCIII) to A.M.V
As this litigation grows, Novo Nordisk could spend billions of dollars to litigate and settle lawsuits about Ozempic and its other GLP-1 drugs
Statistical Analysis All statistical results were conducted using Statistical Analysis System 9.4 version (SAS Institute Inc., Cary, NC, USA)
Suggested Use: As a dietary supplement, take 1 capsule twice daily, or as directed by a health practitioner
Over three to twelve months of well-managed peptide therapy, patients commonly see: Improved growth hormone signaling and rising IGF-1 levels A more favorable cortisol curve with less stress-related disruption Better fasting insulin, blood sugar control, and A1C Sex hormones stabilizing relative to age and life stage Enhanced sleep quality, energy, and cognitive function Reduced body fat and preserved or increased muscle mass Patients may see improvements within weeks while full results can take months

Month 1 Avg 2% starting weight loss, possible side effects, lower appetite Month 2 Avg 4% starting weight loss, side effects may return as dose goes up, even lower appetite Month 3 Avg 6% starting weight loss, new routine in place, may notice more energy Month 4 Avg 8% starting weight loss, maintenance dose confirmed, focus on long-term success Month 6 Avg 10% starting weight loss, progress may slow but keeping up your routine helps Month 15 Avg 17% starting weight loss, nearing or at your goal weight, focus shifts to maintenance Not everyone has the same experience on weight loss treatment